Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy

被引：0

作者：

Rivas-Delgado, Alfredo ^{[1
]}

Luttwak, Efrat ^{[1
]}

Drill, Esther ^{[2
]}

Goldstein, Ilan ^{[3
]}

Landego, Ivan ^{[3
,4
]}

Tomas, Ana Alarcon ^{[3
]}

Parascondola, Allison ^{[3
]}

Saldia, Amethyst ^{[3
]}

Caron, Philip ^{[1
]}

Dahi, Parastoo B. ^{[3
,4
]}

Epstein-Peterson, Zachary D. ^{[1
]}

Falchi, Lorenzo ^{[1
]}

Hamlin, Paul A. ^{[1
]}

Johnson, William ^{[1
,4
]}

Kumar, Anita ^{[5
]}

Lin, Richard J. ^{[3
,4
]}

Lue, Jennifer Kimberly ^{[1
]}

Owens, Colette ^{[1
]}

Noy, Ariela ^{[1
]}

Scordo, Michael ^{[3
,4
]}

Dogan, Ahmet ^{[6
]}

Seshan, Venkatraman ^{[2
]}

Zelenetz, Andrew D. ^{[1
]}

Perales, Miguel-Angel ^{[3
,4
]}

Shouval, Roni ^{[3
,4
]}

Palomba, Maria Lia ^{[1
,4
]}

Shah, Gunjan L. ^{[3
,4
]}

Salles, Gilles ^{[1
,4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, Barcelona, Spain

[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-187379

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[21] HEMATOTOXICITY POST CAR-T CELL THERAPY: REAL-WORLD DATA ON RISK FACTORS AND OUTCOMES
Bousiou, Zoi
Kyriakou, Ioannis
Vardi, Anna
Mallouri, Despoina
Gavriilaki, Eleni
Demosthenous, Christos
Spyridis, Nikolaos
Panteliadou, Alkistis-Kyra
Papchianou, Eleni
Karavalakis, Georgios
Yannaki, Evangelia
Batsis, Ioannis
Sakellari, Ioanna
BONE MARROW TRANSPLANTATION, 2024, 59 : 218 - 219
[22] Real-world experience with CAR-T therapy with Brexucabtagene Autoleucel for advanced relapsed mantle cell lymphoma
Heini, A.
Kronig, M. -N.
Bacher, U.
Taleghani, B. Mansouri
Novak, U.
Pabst, T.
SWISS MEDICAL WEEKLY, 2021, 151 : 2 - 2
[23] Trial in Progress: Follicular Lymphoma Outcomes in Relapsed/Refractory Patients Treated with Systemic Therapy in a Real-World Assessment (FLORA)
Bachy, Emmanuel
Damaj, Gandhi Laurent
Ma, Qiufei
Hampp, Christian
Harnett, James
Sobel, Rachel E.
Jalbert, Jessica J.
Quek, Ruben G. W.
Wei, Wenhui
Wu, Ning
Mastey, Vera
Wang, Joy
Bajwa, Anit
Maissenhaelter, Benedikt
van Gils, Chantal
Aggarwal, Shivani
Chaudhry, Aafia
Mohamed, Hesham
Ambati, Srikanth R.
Thieblemont, Catherine
BLOOD, 2022, 140 : 5198 - 5200
[24] CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
Nobles, Christopher L.
Sherrill-Mix, Scott
Everett, John K.
Reddy, Shantan
Fraietta, Joseph A.
Porter, David L.
Frey, Noelle
Gill, Saar I.
Grupp, Stephan A.
Maude, Shannon L.
Siegel, Donald L.
Levine, Bruce L.
June, Carl H.
Lacey, Simon F.
Melenhorst, J. Joseph
Bushman, Frederic D.
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (02): : 673 - 685
[25] First Analyses of Transcriptomic Changes in the Skin of SSc Patients upon CD19-targeting CAR T Cell Therapy
Auth, Janina
Selvaraju, Manoj Kumar
Mueller, Fabian
Gupta, Pooja
Ekici, Arif
Tur, Carlo
Raimondo, Maria Gabriella
Distler, Joerg
Dees, Clara
Chenguiti, Sara
Hagen, Melanie
Wirsching, Andreas
Taubmann, Jule
Kharboutli, Soraya
Spoerl, Silvia
Aigner, Michael
Kretschmann, Sascha
Vasova, Ingrid
MAckensen, Andreas
Schett, Georg
Bergmann, Christina
ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1644 - 1646
[26] Cognitive, neurological, and psychological presentation in patients planned for CAR-T therapy: a real-world approach
Kuznetsova, Valeriya
Oza, Harsh
Rosenfeld, Hannah
Sales, Carmela
van der Linde, Samantha
Roos, Izanne
Roberts, Stefanie
D'Aprano, Fiore
Loi, Samantha M.
Dowling, Mark
Dickinson, Michael
Kalincik, Tomas
Harrison, Simon J.
Anderson, Mary Ann
Malpas, Charles B.
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (04) : 35 - 36
[27] Real-World Outcomes of Early Relapsed/Refractory Large B Cell Lymphoma Patients Treated with 2 nd Line CAR T Therapy
Schneider, Michael
Chong, Elise A.
Barta, Stefan K.
Nasta, Sunita D.
Svoboda, Jakub
Carter, Jordan
Cook, Michael Roderick
Hossain, Nasheed
Schuster, Stephen J.
Difilippo, Heather
Plastaras, John P.
Lariviere, Michael
Ruella, Marco
Porter, David L.
Frey, Noelle
Landsburg, Daniel J.
BLOOD, 2024, 144 : 5123 - 5124
[28] Anti-CD19 CAR-T Cell Therapy in Elderly Patients: Multicentric Real-World Experience from GETH-TC/GELTAMO
Bailen, Rebeca
Iacoboni, Gloria
Delgado, Javier
Lopez-Corral, Lucia
Hernani-Morales, Rafael
Ortiz-Maldonado, Valentin
Guerreiro, Manuel
Caballero, Ana Carolina
Guerra-Dominguez, Maria Luisa
Sanchez-Pina, Jose Maria
Pena, Marta
Torrent, Anna
Perez-Martinez, Antonio
Bastos-Oreiro, Mariana
Reguera-Ortega, Juan Luis
Martin, Alejandro
Hernandez-Boluda, Juan Carlos
Martinez-Cibrian, Nuria
Sanz, Jaime
Briones, Javier
Henriquez, Hugo Luzardo
Calbacho, Maria
Mussetti, Alberto
Sancho, Juan Manuel
Barba, Pere
Kwon, Mi
TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (10):
[29] Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
Saha, Aditi
Jhaveri, Khushali
Sarfraz, Humaira
Chavez, Julio C.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, : 869 - 876
[30] Tisagenlecleucel: CAR-T cell therapy for adult patients with relapsed or refractory follicular lymphoma
Saha, Aditi
Jhaveri, Khushali
Sarfraz, Humaira
Chavez, Julio C.
EXPERT OPINION ON BIOLOGICAL THERAPY, 2023,

← 1 2 3 4 5 →